GE Healthcare to expand Indian life sciences footprint

Image
Announcement Corporate
Last Updated : Jan 29 2013 | 3:14 AM IST

Exclusive distribution agreement with Spinco Biotech provides customers with improved access to life sciences product range 

GE Healthcare, a unit of General Electric Company (NYSE: GE), expands its life sciences footprint in India with an exclusive distribution agreement with Spinco Biotech, a leading distributor of analytical and life science instruments, reagents and chemicals.

Customers will now have access to a range of GE Healthcare’s life sciences products including chemicals, membrane and films, electrophoresis units and reagents, sample prep, bioassays and chromatography media products through this distribution partnership. This will provide customers with an unparalleled combination of more compelling solutions, product quality and value.

GE Healthcare will also continue as a direct distributor in India for its flagship bioprocessing and drug discovery product ranges such as ÄKTA™, Biacore™ and IN Cell, as well as offering technical and service support to all customers.

The life sciences division of GE Healthcare delivers breakthroughs in drug discovery, biopharmaceutical research and manufacturing and the latest in cellular technologies so scientists and specialists can discover news ways to predict, diagnose and treat diseases earlier. The business also makes systems and equipment for the purification of biopharmaceuticals.  GE Healthcare’s life sciences business has been steadily increasing its footprint in India with the setting up a R&D center, Fast Trak™ BioPharma Services and an education center in Bangalore.

“We are confident that this new distribution relationship with Spinco will only further strengthen our capabilities to provide better solutions for the life science research community and support to our customers,” said Mr. Anurag Gupta, Managing Director Life Sciences, GE Healthcare India.

Mr. S. Thyagarajan, Chairman, Spinco Group of companies, India said: “This is a defining moment in the history of Spinco and the Indian life sciences industry. The addition of product ranges from GE Healthcare is in line with our commitment of offering total solutions to customers.”

Spinco Biotech has a proven track record of 28 years in serving the scientific community with a network of 26 offices and 300 plus Spinco sites across India and is considered one of the market leaders in life sciences product lines. Spinco is well known for its strong commitment to customer support.

Anurag Gupta, Country Manager of GE Healthcare Life Sciences, India stated: "Spinco adds a very important and complementary channel to our existing customer base in India. The presence Spinco has in the life sciences research and academic sector will increase our coverage and efficiency with customers across India.  We look forward to working with Spinco to make this deal a great success."

GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat, and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection, and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17- billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our Web site at www.gehealthcare.com.

Spinco Biotech Pvt Ltd.
As a leading distributor of Analytical and Life Science Instrumentation we are committed to excellence in every function of our business - using people, knowledge, innovation and technology to provide our customers with products of the highest quality and world class services. Our endeavor has always been to delight customers in whatever we do.  Our Business Philosophy has been driven by the passion for excellence, and people focus. We rededicate ourselves in our mission to serve our customers with superior products and be a part of their success stories.

Spinco Biotech is the distributor for Shimadzu HPLC over 25 years particularly for HPLC.  They are also exclusively distributing  Affymetrix Inc., USA; Molecular Devices Corporation - now part of MDS Analytical Technologies, USA;  in India. For more information about Spinco Biotech, visit www.spincotech.com

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 23 2008 | 12:00 AM IST

Next Story